Mitsui led a $16.8m round for the green energy and clean energy product supplier, investing together with undisclosed existing backers.
Author: Jack Hammond
Phylagen traces corporates for $14m series A
The environmental microbiome testing kit maker has collected capital from investors including Western Digital Capital, 3M Ventures and Agfunder in its series A round.
Eli Lilly enters Passage Bio in series A round
Passage Bio has launched to develop treatments for diseases affecting the central nervous system, after raising almost $116m in a series A round backed by Lilly Asia Ventures.
CK Hutchinson ventures into Sight Diagnostics’ series C
CK Hutchinson’s Longliv fund has made its first investment, leading the medical diagnostic system producer’s $27.8m series C round.
OP helps operate Nordcloud funding
OP Corporate Bank has backed a $22.6m round for Nordcloud, which the cloud infrastructure developer will use to hire new staff and grow internationally.
Mitsubishi charts further DMP investment
Mitsubishi Electric Corporation and INCJ provided a total of $36m for the mapping technology developer while Japan Infrastructure Initiative added an undisclosed amount.
Sciwind blows through series A stage
Legend Capital led a $29.5m round for SciWind, which is developing treatments for metabolic and liver diseases, with backing from Kawin Technology.
Depsys deepens cash reserves in series B round
The Statkraft-backed energy management software producer has secured $13.1m series B funding from financial services firm BNP Paribas and Set Ventures.
Joor soars in $16m series C
The wholesale fashion e-commerce platform will expand into Asia with the proceeds from the Itochu-led round, which boosted its total funding to $36m.
Catapult Capital catches JibJab
Catapult has partnered St. Cloud Capital to buy the electronic greeting card platform for an undisclosed sum, allowing Sony and Overbrook Entertainment to exit.
MassMutual finds Affinity in series B round
Mutual Life Insurance has tapped its investment unit to take part in a $26.5m round that increased the business relationship platform operator’s overall funding to more than $40m.
Arvelle arrives with $100m
Axovant Sciences has spun out its small molecule team into a startup called Arvelle, which will develop an anti-epileptic drug after raising more than $100m in external funding.
GM makes way to Wejo with $25m
General Motors has reportedly purchased a 35% stake in the automotive data sharing platform through a cash and data deal that valued it at $275m.
Vor roars to $42m series A
Novartis and Johnson & Johnson have contributed to a series A round for Vor Biopharma, an oncology drug developer co-founded by PureTech Health.